Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema
Emphysema: Outcomes and Technology Assessment
2 other identifiers
observational
802
1 country
1
Brief Summary
Emphysema is a lung disease that involves damage to the air sacs in the lungs and can lead to breathing difficulties. Treatment options for people with emphysema include pulmonary rehabilitation, lung volume reduction surgery, and lung transplantation. This study will observe people with emphysema to assess the effect of these treatment therapies on their quality of life and long-term health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2000
CompletedFirst Submitted
Initial submission to the registry
May 7, 2008
CompletedFirst Posted
Study publicly available on registry
May 9, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 11, 2015
CompletedDecember 2, 2021
November 1, 2021
15.7 years
May 7, 2008
November 30, 2021
Conditions
Keywords
Eligibility Criteria
Participants with moderate to severe emphysema who are undergoing pulmonary rehabilitation, lung volume reduction surgery, or lung transplantation.
You may qualify if:
- Diagnosed with emphysema
- Referred for pulmonary rehabilitation, lung volume reduction surgery, or lung transplantation
You may not qualify if:
- Non-obstructive lung disease
- Chronic obstructive pulmonary disease (COPD) that is not predominantly due to emphysema
- Inability to read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine and Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roger D. Yusen, MD, MPH
Washington University School of Medicine, St. Louis
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2008
First Posted
May 9, 2008
Study Start
January 1, 2000
Primary Completion
September 11, 2015
Study Completion
September 11, 2015
Last Updated
December 2, 2021
Record last verified: 2021-11